| Application of the Gyrolab™ platform to ligand-binding assays: a user’s perspective JR Mora, L Obenauer-Kutner, V Vimal Patel Bioanalysis 2 (10), 1711-1715, 2010 | 59 | 2010 |
| The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with … MF Abdelmalek, ED Charles, AJ Sanyal, SA Harrison, ... Contemporary clinical trials 104, 106335, 2021 | 58 | 2021 |
| Pharmacokinetic, pharmacodynamic, and safety profile of a novel anti‐CD28 domain antibody antagonist in healthy subjects R Shi, M Honczarenko, S Zhang, C Fleener, J Mora, SK Lee, R Wang, ... The Journal of Clinical Pharmacology 57 (2), 161-172, 2017 | 34 | 2017 |
| Next generation ligand binding assays—review of emerging technologies’ capabilities to enhance throughput and multiplexing J Mora, AG Chunyk, M Dysinger, S Purushothama, C Ricks, K Österlund, ... The AAPS Journal 16, 1175-1184, 2014 | 34 | 2014 |
| Enzymatic microRNA detection in microtiter plates with DNA dendrimers JR Mora, RC Getts Biotechniques 41 (4), 420-424, 2006 | 24 | 2006 |
| Biotherapeutic bioanalysis: a multi-indication case study review HA Myler, A Given, K Kolz, JR Mora, G Hristopoulos Bioanalysis 3 (6), 623-643, 2011 | 22 | 2011 |
| Development of a generic anti-PEG antibody assay using bioscale’s acoustic membrane microparticle technology H Dong, JR Mora, C Brockus, SD Chilewski, R Dodge, C Merrifield, ... The AAPS journal 17, 1511-1516, 2015 | 21 | 2015 |
| Development and validation of an LC–MS/MS assay for the quantitation of a PEGylated anti-CD28 domain antibody in human serum: overcoming interference from antidrug antibodies … C Gong, J Zeng, B Akinsanya, H Jiang, J Mora, S Chilewski, ... Bioanalysis 6 (18), 2371-2383, 2014 | 21 | 2014 |
| High-sensitivity detection methods for low-abundance RNA species: applications for functional genomics research JR Mora, RC Getts Expert review of molecular diagnostics 7 (6), 775-785, 2007 | 16 | 2007 |
| Immunogenicity risk assessment for PEGylated therapeutics JR Mora, JT White, SL DeWall The AAPS Journal 22, 1-12, 2020 | 14 | 2020 |
| Protein detection enhanced by 3DNA dendrimer signal amplification JR Mora, TL Zielinski, BP Nelson, RC Getts BioTechniques 44 (6), 815-818, 2008 | 13 | 2008 |
| Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium M Starcevic Manning, M Hassanein, MA Partridge, V Jawa, J Mora, ... The AAPS Journal 24 (4), 81, 2022 | 12 | 2022 |
| Emerging technologies for biotherapeutic bioanalysis from a high-throughput and multiplexing perspective: insights from an AAPS emerging technology action program committee S Purushothama, M Dysinger, Y Chen, K Österlund, J Mora, AG Chunyk, ... Bioanalysis 10 (3), 181-194, 2018 | 12 | 2018 |
| Elotuzumab: serum protein electrophoresis and immunofixation interference with clinical assessment of M-protein response in relapsed/refractory multiple myeloma (RRMM) M Dimopoulos, S Lonial, LF Casado, M Golightly, C Doyen, S Shelat, ... Clinical Lymphoma, Myeloma and Leukemia 15, e267-e268, 2015 | 12 | 2015 |
| Given Chunyk A, Dysinger M, Purushothama S, Ricks C, Osterlund K, et al. Next generation ligand binding assays-review of emerging technologies’ capabilities to enhance … J Mora Aaps j 16 (6), 1175-84, 2014 | 12 | 2014 |
| Dendrimer FISH detection of single-copy intervals in acute promyelocytic leukemia JR Mora, JHM Knoll, PK Rogan, RC Getts, GS Wilson Molecular and cellular probes 20 (2), 114-120, 2006 | 12 | 2006 |
| The clinical pharmacology of elotuzumab C Passey, J Sheng, J Mora, A Tendolkar, M Robbins, R Dodge, A Roy, ... Clinical Pharmacokinetics 57, 297-313, 2018 | 11 | 2018 |
| Addressing matrix effects in ligand-binding assays through the use of new reagents and technology SD Chilewski, JR Mora, C Gleason, B DeSilva Bioanalysis 6 (8), 1059-1067, 2014 | 10 | 2014 |
| An integrated assessment of the effects of immunogenicity on the pharmacokinetics, safety, and efficacy of elotuzumab C Passey, J Mora, R Dodge, L Gibiansky, J Sheng, A Roy, A Bello, ... The AAPS journal 19, 557-567, 2017 | 9 | 2017 |
| Neutralizing Antibody Validation Testing and Reporting Harmonization H Myler, J Pedras-Vasconcelos, T Lester, F Civoli, W Xu, B Wu, ... The AAPS journal 25 (4), 69, 2023 | 8 | 2023 |
